Literature DB >> 23091237

Arterial spin labeling in patients with chronic cerebral artery steno-occlusive disease: correlation with (15)O-PET.

Hironori Kamano1, Takashi Yoshiura, Akio Hiwatashi, Koichiro Abe, Osamu Togao, Koji Yamashita, Hiroshi Honda.   

Abstract

BACKGROUND: Heterogeneity of arterial transit time due to cerebral artery steno-occlusive lesions hampers accurate regional cerebral blood flow measurement by arterial spin labeling (ASL).
PURPOSE: To assess the feasibility of regional cerebral blood flow measurement by ASL with multiple-delay time sampling in patients with steno-occlusive diseases by comparing with positron emission tomography (PET), and to determine whether regional arterial transit time measured by this ASL technique is correlated with regional mean transit time, a PET index of perfusion pressure.
MATERIAL AND METHODS: Sixteen patients with steno-occlusive diseases received both ASL and (15)O-PET. The mean regional cerebral blood flow measured by ASL and PET, regional arterial transit time by ASL, and regional mean transit time by PET were obtained by a region-of-interest analysis. Correlation between regional cerebral blood flow by ASL and that by PET, and correlation between regional arterial transit time by ASL and regional mean transit time by PET were tested using Pearson's correlation coefficient for both absolute and relative values. A multivariate regression analysis was performed to test whether regional arterial transit time by ASL was a significant contributor in modeling regional mean transit time by PET after controlling the effect of regional cerebral blood flow by ASL.
RESULTS: A significant positive correlation was found between regional cerebral blood flow by ASL and that by PET for both absolute (r = 0.520, P < 0.0001) and relative (r = 0.691, P < 0.0001) values. A significant positive correlation was found between regional arterial transit time by ASL and regional mean transit time by PET both for absolute (r = 0.369, P = 0.0002) and relative (r = 0.443, P < 0.0001) values. The regression analysis revealed that regional arterial transit time by ASL was a significant contributor in modeling regional mean transit time by PET after controlling regional cerebral blood flow by ASL (P = 0.0011).
CONCLUSION: The feasibility of regional cerebral blood flow measurement using ASL with multiple-delay time sampling was confirmed in patients with cerebral artery steno-occlusive diseases. Moreover, it was suggested that mapping of regional arterial transit time has the potential to detect hemodynamic impairment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23091237     DOI: 10.1258/ar.2012.120450

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  13 in total

1.  3D GRASE pulsed arterial spin labeling at multiple inflow times in patients with long arterial transit times: comparison with dynamic susceptibility-weighted contrast-enhanced MRI at 3 Tesla.

Authors:  Steve Z Martin; Vince I Madai; Federico C von Samson-Himmelstjerna; Matthias A Mutke; Miriam Bauer; Cornelius X Herzig; Stefan Hetzer; Matthias Günther; Jan Sobesky
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

Review 2.  Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review.

Authors:  Audrey P Fan; Hesamoddin Jahanian; Samantha J Holdsworth; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

3.  "Imaging Evaluation of Collaterals in the Brain: Physiology and Clinical Translation"

Authors:  Sunil A Sheth; David S Liebeskind
Journal:  Curr Radiol Rep       Date:  2014-01

4.  Quantitative T2, T2*, and T2' MR imaging in patients with ischemic leukoaraiosis might detect microstructural changes and cortical hypoxia.

Authors:  Marlies Wagner; Michael Helfrich; Steffen Volz; Jörg Magerkurth; Stella Blasel; Luciana Porto; Oliver C Singer; Ralf Deichmann; Alina Jurcoane; Elke Hattingen
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

5.  Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease.

Authors:  Tetsuya Tsujikawa; Hirohiko Kimura; Tsuyoshi Matsuda; Yasuhiro Fujiwara; Makoto Isozaki; Ken-Ichiro Kikuta; Hidehiko Okazawa
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

Review 6.  A neuroradiologist's guide to arterial spin labeling MRI in clinical practice.

Authors:  M Grade; J A Hernandez Tamames; F B Pizzini; E Achten; X Golay; M Smits
Journal:  Neuroradiology       Date:  2015-09-09       Impact factor: 2.804

7.  Exercise Training Increases Parietal Lobe Cerebral Blood Flow in Chronic Stroke: An Observational Study.

Authors:  Andrew D Robertson; Susan Marzolini; Laura E Middleton; Vincenzo S Basile; Paul I Oh; Bradley J MacIntosh
Journal:  Front Aging Neurosci       Date:  2017-09-29       Impact factor: 5.750

8.  Arterial Transit Time-corrected Renal Blood Flow Measurement with Pulsed Continuous Arterial Spin Labeling MR Imaging.

Authors:  Kazuhiro Shimizu; Nobuyuki Kosaka; Yasuhiro Fujiwara; Tsuyoshi Matsuda; Tatsuya Yamamoto; Tatsuro Tsuchida; Katsuki Tsuchiyama; Nobuyuki Oyama; Hirohiko Kimura
Journal:  Magn Reson Med Sci       Date:  2016-05-09       Impact factor: 2.471

9.  Evaluation of Arterial Spin Labeling MRI-Comparison with 15O-Water PET on an Integrated PET/MR Scanner.

Authors:  Markus Fahlström; Lieuwe Appel; Eva Kumlien; Torsten Danfors; Mathias Engström; Johan Wikström; Gunnar Antoni; Elna-Marie Larsson; Mark Lubberink
Journal:  Diagnostics (Basel)       Date:  2021-05-01

10.  Clinical evaluation of an arterial-spin-labeling product sequence in steno-occlusive disease of the brain.

Authors:  Matthias A Mutke; Vince I Madai; Federico C von Samson-Himmelstjerna; Olivier Zaro Weber; Gajanan S Revankar; Steve Z Martin; Katharina L Stengl; Miriam Bauer; Stefan Hetzer; Matthias Günther; Jan Sobesky
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.